SCHEMBL1104948

SCHEMBL1104948

Cc1ccc2c(c1)C(C)(C)c1cc(-c3c4ccccc4c(-c4ccccc4)c4ccncc34)ccc1-2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
MAPT P10636 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
MEN1 O00255 1/20 0.39
RECQL P46063 1/20 0.39
KMT2A Q03164 1/20 0.39
MAP2 P11137 1/20 0.35
PDK2 Q15119 2/20 0.34
CYP17A1 P05093 3/20 0.33
DHODH Q02127 1/20 0.33
TNF P01375 1/20 0.33
ALOX5 P09917 1/20 0.33
PIK3CD O00329 1/20 0.33
CYP2A6 P11509 1/20 0.33
ACHE P22303 1/20 0.33
MAP2K4 P45985 1/20 0.32
IMPDH2 P12268 1/20 0.32
CCNC P24863 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1104944 0.96 KDM4E (0.38) LMNAKDM4EALDH1A1MAPTNPSR1
SCHEMBL16298678 0.94 LMNA (0.37) LMNAKDM4EALDH1A1MAPTNPSR1
SCHEMBL1102673 0.94 PDK2 (0.37) MAP2PDK2CYP17A1DHODHTNF
SCHEMBL10072719 0.93 PDK2 (0.39) LMNAKDM4EALDH1A1MAPTNPSR1
SCHEMBL1102686 0.91 PDK2 (0.38) MAP2PDK2DHODHTNFALOX5
SCHEMBL16298709 0.91 PDK2 (0.39) LMNAKDM4EALDH1A1MAPTNPSR1
SCHEMBL1102790 0.90 PDK2 (0.40) MAP2PDK2CYP17A1DHODHTNF
SCHEMBL1102613 0.90 PDK2 (0.40) MAP2PDK2CYP17A1DHODHTNF
SCHEMBL1102678 0.90 PDK2 (0.39) MAP2PDK2DHODHTNFALOX5
SCHEMBL1102542 0.90 PDK2 (0.39) MAP2PDK2DHODHTNFALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same ORMDL3, OCIAD2, OCIAD1 LMNA 2738/4885KDM4E 3367/4885ALDH1A1 1015/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.